|
1
|
Sakr Y, Elia C, Mascia L, Barberis B,
Cardellino S, Livigni S, Fiore G, Filippini C and Ranieri VM:
Epidemiology and outcome of sepsis syndromes in Italian ICUs: a
muticentre, observational cohort study in the region of Piedmont.
Minerva Anestesiol. 79:993–1002. 2013.PubMed/NCBI
|
|
2
|
Kobashi H, Toshimori J and Yamamoto K:
Sepsis-associated liver injury: incidence, classification and the
clinical significance. Hepatol Res. 43:255–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Diament D, Salomão R, Rigatto O, Gomes B,
Silva E, Carvalho NB and Machado FR: Guidelines for the treatment
of severe sepsis and septic shock - management of the infectious
agent - diagnosis. Rev Bras Ter Intensiva. 23:134–144. 2011.(In
Portuguese). PubMed/NCBI
|
|
4
|
Dellinger RP, Levy MM, Rhodes A, Annane D,
Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke
R, et al: Surviving Sepsis Campaign Guidelines Committee including
The Pediatric Subgroup: Sepsis Campaign: international guidelines
for management of severe sepsis and septic shock, 2012. Intensive
Care Med. 39:165–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fukushima H, Nishio K, Asai H, Watanabe T,
Seki T, Matsui H, Sugimoto M, Matsumoto M, Fujimura Y and Okuchi K:
Ratio of von Willebrand factor propeptide to ADAMTS13 is associated
with severity of sepsis. Shock. 39:409–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hatherill M, Tibby SM, Turner C, Ratnavel
N and Murdoch IA: Procalcitonin and cytokine levels: relationship
to organ failure and mortality in pediatric septic shock. Crit Care
Med. 28:2591–2594. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
King EG, Bauzá GJ, Mella JR and Remick DG:
Pathophysiologic mechanisms in septic shock. Lab Invest. 94:4–12.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aslani F, Schuppe HC, Guazzone VA, Bhushan
S, Wahle E, Lochnit G, Lustig L, Meinhardt A and Fijak M: Targeting
high mobility group box protein 1 ameliorates testicular
inflammation in experimental autoimmune orchitis. Hum Reprod.
30:417–431. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Subramani J, Kathirvel K, Leo MD,
Kuntamallappanavar G, Uttam Singh T and Mishra SK: Atorvastatin
restores the impaired vascular endothelium-dependent relaxations
mediated by nitric oxide and endothelium-derived hyperpolarizing
factors but not hypotension in sepsis. J Cardiovasc Pharmacol.
54:526–534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu X, Zhao L and Xu YH: Low molecular
weight heparin prevents CLP-induced acute lung injury in rats by
anti-inflammatory coagulation. Bosn J Basic Med Sci. 13:50–56.
2013.PubMed/NCBI
|
|
11
|
Liu FY and Liu TF: Experimental zoology.
Beijing China Science and Technology Press. Beijing: 209–210.
2005.(In Chinese).
|
|
12
|
Wichterman KA, Baue AE and Chaudry IH:
Sepsis and septic shock - a review of laboratory models and a
proposal. J Surg Res. 29:189–201. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Levi M, van der Poll T and Schultz M: New
insights into pathways that determine the link between infection
and thrombosis. Neth J Med. 70:114–120. 2012.PubMed/NCBI
|
|
14
|
Schouten M, Wiersinga WJ, Levi M and van
der Poll T: Inflammation, endothelium, and coagulation in sepsis. J
Leukoc Biol. 83:536–545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L and An YZ: The stage-biomarkers of
the sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 23:509–512.
2011.(In Chinese). PubMed/NCBI
|
|
16
|
Khalid U, Jenkins RH, Pino-Chavez G, Bowen
T, Fraser DJ and Chavez R: A localized ischemic preconditioning
regimen increases tumor necrosis factor α expression in a rat model
of kidney ischemia-reperfusion injury. Exp Clin Transplant.
13:535–542. 2015.PubMed/NCBI
|
|
17
|
Zou JL, Yin ZP, Zhang LQ, Wang YQ and Qi
GX: Expression of TNG-α and IL-6 in tissues and serums in the early
stage of myocardial ischemia-reperfusion in rat. J China Med Univ.
25:541–543. 2013.(In Chinese).
|
|
18
|
Zhao L, An R, Yang Y, Yang X, Liu H, Yue
L, Li X, Lin Y, Reiter RJ and Qu Y: Melatonin alleviates brain
injury in mice subjected to cecal ligation and puncture via
attenuating inflammation, apoptosis, and oxidative stress: the role
of SIRT1 signaling. J Pineal Res. 59:230–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bosmann M, Russkamp NF and Ward PA:
Fingerprinting of the TLR4-induced acute inflammatory response. Exp
Mol Pathol. 93:319–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu H, Cai PP, Yin X and Zhu J: Role of
high mobility group protein B1 in acute lung injury in rats with
sepsis. Chin J Crit Care Med. 23:253–254. 2011.(In Chinese).
|
|
21
|
Ito T, Kawahara K, Nakamura T, Yamada S,
Nakamura T, Abeyama K, Hashiguchi T and Maruyama I: High-mobility
group box 1 protein promotes development of microvascular
thrombosis in rats. J Thromb Haemost. 5:109–116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H and Liu D: Baicalin inhibits
high-mobility group box 1 release and improves survival in
experimental sepsis. Shock. 41:324–330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SA, Kwak MS, Kim S and Shin JS: The
role of high mobility group box 1 in innate immunity. Yonsei Med J.
55:1165–1176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kouroumichakis I, Papanas N, Proikaki S,
Zarogoulidis P and Maltezos E: Statins in prevention and treatment
of severe sepsis and septic shock. Eur J Intern Med. 22:125–133.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Janda S, Young A, Fitzgerald JM, Etminan M
and Swiston J: The effect of statins on mortality from severe
infections and sepsis: a systematic review and meta-analysis. J
Crit Care. 25:656.e7–22. 2010. View Article : Google Scholar
|
|
26
|
Beffa DC, Fischman AJ, Fagan SP, Hamrahi
VF, Paul KW, Kaneki M, Yu YM, Tompkins RG and Carter EA:
Simvastatin treatment improves survival in a murine model of burn
sepsis: role of interleukin 6. Burns. 37:222–226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jaimes F, De La Rosa G, Morales C, Fortich
F, Arango C, Aguirre D and Muñoz A: Unfractioned heparin for
treatment of sepsis: a randomized clinical trial (The HETRASE
Study). Crit Care Med. 37:1185–1196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao D, Ding R, Mao Y, Wang L, Zhang Z and
Ma X: Heparin rescues sepsis-associated acute lung injury and
lethality through the suppression of inflammatory responses.
Inflammation. 35:1825–1832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Spratte J, Meyer zu Schwabedissen H,
Endlich N, Zygmunt M and Fluhr H: Heparin inhibits TNF-α signaling
in human endometrial stromal cells by interaction with NF-κB. Mol
Hum Reprod. 19:227–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu ZY, Zhu H and Ma XC: Systematic
evaluation of heparin treatment in sepsis. Chin J Crit Care Med.
26:135–141. 2014.(In Chinese).
|
|
31
|
Wang P, Wang X, Zhang LJ, Yang F, Wang GX,
Li XL and Huang X: Effect of low molecular weight heparin on the
prognosis of elderly patients with severe pneumonia. Chin J Crit
Care Med. 25:734–737. 2013.(In Chinese).
|
|
32
|
Gill SE, Taneja R, Rohan M, Wang L and
Mehta S: Pulmonary microvascular albumin leak is associated with
endothelial cell death in murine sepsis-induced lung injury in
vivo. PLoS One. 9:e885012014. View Article : Google Scholar : PubMed/NCBI
|
